Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
11.95
-0.03 (-0.25%)
At close: Dec 5, 2025, 4:00 PM EST
11.93
-0.02 (-0.17%)
After-hours: Dec 5, 2025, 7:37 PM EST

Kura Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1,0406771,0688479322,157
Upgrade
Market Cap Growth
-16.21%-36.58%26.07%-9.08%-56.80%246.13%
Upgrade
Enterprise Value
5102396334253961,847
Upgrade
Last Close Price
11.958.7114.3812.4114.0032.66
Upgrade
PS Ratio
10.0512.57----
Upgrade
PB Ratio
4.291.642.692.021.843.53
Upgrade
P/TBV Ratio
4.291.642.692.021.843.53
Upgrade
P/FCF Ratio
12.515.06----
Upgrade
P/OCF Ratio
11.845.04----
Upgrade
EV/Sales Ratio
4.904.43----
Upgrade
EV/FCF Ratio
6.131.78----
Upgrade
Debt / Equity Ratio
0.080.040.040.030.010.03
Upgrade
Debt / FCF Ratio
0.230.12----
Upgrade
Asset Turnover
0.180.09----
Upgrade
Quick Ratio
4.839.3212.0518.2423.1324.34
Upgrade
Current Ratio
5.129.4612.2618.5623.2624.49
Upgrade
Return on Equity (ROE)
-65.10%-42.91%-37.34%-29.31%-23.35%-21.60%
Upgrade
Return on Assets (ROA)
-26.57%-19.97%-22.89%-17.65%-13.89%-12.92%
Upgrade
Return on Capital (ROIC)
-42.68%-28.59%-24.42%-18.45%-14.40%-13.48%
Upgrade
Return on Capital Employed (ROCE)
-45.40%-28.40%-40.10%-32.40%-25.70%-14.80%
Upgrade
Earnings Yield
-20.86%-25.69%-14.29%-16.04%-14.00%-4.16%
Upgrade
FCF Yield
7.99%19.76%-11.70%-13.07%-11.34%-3.34%
Upgrade
Buyback Yield / Dilution
-4.45%-17.66%-9.31%-0.96%-25.01%-26.54%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.